# Trade Mark Journal No.2026/026 26 June 2026

## WO0000001921711 (5)

Office of origin: United States of America

Date of International Registration:16 April 2026
Date of designation in the UK: 16 April 2026

The mark consists of the stylized wording, "ZENDDMYA" where the letters, "ZEN" and "MYA" are featured in dark blue, while the letters, "DD" are featured in a gradient color pattern from dark blue at the bottom of the letters to light blue at the top.

The mark contains the colours dark blue and light blue.

The mark consists of the stylized wording, "ZENDDMYA" where the letters, "ZEN" and "MYA" are featured in dark blue, while the letters, "DD" are featured in a gradient color pattern from dark blue at the bottom of the letters to light blue at the top.

International priority date claimed: 4 November 2025 (United States of America) (99479136)

Class 5
  Pharmaceutical preparations for the treatment of cancer and tumors, and autoimmune diseases and disorders; biological preparations for the treatment of cancer; biologics in the nature of pharmaceutical preparations for the treatment of cancer.

Kite Pharma, Inc.

Representative: Cynthia Smuzynska Gilead Sciences, Inc., 333 Lakeside Drive, Foster City CA 94404, UNITED STATES OF AMERICA